1. Home
  2. VRTS vs WVE Comparison

VRTS vs WVE Comparison

Compare VRTS & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtus Investment Partners Inc.

VRTS

Virtus Investment Partners Inc.

N/A

Current Price

$168.14

Market Cap

1.1B

Sector

Finance

ML Signal

N/A

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$5.09

Market Cap

994.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VRTS
WVE
Founded
1988
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
994.1M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
VRTS
WVE
Price
$168.14
$5.09
Analyst Decision
Hold
Strong Buy
Analyst Count
4
16
Target Price
$158.00
$29.81
AVG Volume (30 Days)
120.0K
2.9M
Earning Date
05-01-2026
04-28-2026
Dividend Yield
6.68%
N/A
EPS Growth
18.24
N/A
EPS
7.72
N/A
Revenue
N/A
$3,704,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.66
$85.67
P/E Ratio
$21.90
N/A
Revenue Growth
N/A
149.43
52 Week Low
$121.61
$5.01
52 Week High
$203.61
$21.73

Technical Indicators

Market Signals
Indicator
VRTS
WVE
Relative Strength Index (RSI) 58.49 39.41
Support Level $161.58 N/A
Resistance Level $171.02 $6.39
Average True Range (ATR) 5.31 0.36
MACD -0.26 -0.06
Stochastic Oscillator 82.15 16.07

Price Performance

Historical Comparison
VRTS
WVE

About VRTS Virtus Investment Partners Inc.

Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: